These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29860985)

  • 1. Epigenetic Priming in Cancer Initiation.
    Vicente-Dueñas C; Hauer J; Cobaleda C; Borkhardt A; Sánchez-García I
    Trends Cancer; 2018 Jun; 4(6):408-417. PubMed ID: 29860985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Making of Leukemia.
    González-Herrero I; Rodríguez-Hernández G; Luengas-Martínez A; Isidro-Hernández M; Jiménez R; García-Cenador MB; García-Criado FJ; Sánchez-García I; Vicente-Dueñas C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.
    Vicente-Dueñas C; Hauer J; Ruiz-Roca L; Ingenhag D; Rodríguez-Meira A; Auer F; Borkhardt A; Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():3-9. PubMed ID: 24530939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application.
    Yamada Y; Yamada Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(6):235-247. PubMed ID: 29887568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
    Wooten DJ; Quaranta V
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
    Shah M; Allegrucci C
    Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products in the reprogramming of cancer epigenetics.
    Irshad R; Husain M
    Toxicol Appl Pharmacol; 2021 Apr; 417():115467. PubMed ID: 33631231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Back to the beginning: The initiation of cancer.
    Cobaleda C; Sánchez-García I
    Bioessays; 2013 May; 35(5):413. PubMed ID: 23553938
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer: an epigenetic landscape.
    Dhanasekaran K; Arif M; Kundu TK
    Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
    [No Abstract]   [Full Text] [Related]  

  • 16. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.
    Rasmussen TP
    Semin Cancer Biol; 2019 Aug; 57():36-44. PubMed ID: 30273656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.
    Treviño LS; Wang Q; Walker CL
    Reprod Toxicol; 2015 Jul; 54():136-40. PubMed ID: 25554384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome.
    Soshnev AA; Josefowicz SZ; Allis CD
    Mol Cell; 2016 Jun; 62(5):681-94. PubMed ID: 27259201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
    Capp JP
    Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.